Italy's Angelini Pharma to buy Catalyst Pharmaceuticals for $4.1 billion

Catalyst Pharmaceuticals

07/05/2026 07:22

May 7 (Reuters) - Italy's Angelini Pharma said on Thursday it has agreed to acquire Catalyst Pharmaceuticals CPRX.O for $4.1 billion.

 (Reporting by Ananya Palyekar in Bengaluru; Editing by Sumana Nandy)

 ((Ananya.Palyekar@thomsonreuters.com;))